Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex

British Journal of Pharmacology

Volumn 162, Issue 4, 2011, Pages 974-988

  Kovacs, Flora E ^a   Illes, Peter ^b   Szabo, Bela ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

ATP; brain slice; CB 1 cannabinoid receptor; cerebellum; endocannabinoid; GABAergic synaptic transmission; patch clamp; purine receptor; retrograde signalling; synaptic plasticity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; PURINERGIC P2X RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM DEPLETION; CALCIUM TRANSPORT; CEREBELLUM CORTEX; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED RESPONSE; EXTRACELLULAR CALCIUM; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PURKINJE CELL; SYNAPTIC TRANSMISSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CEREBELLAR CORTEX; ENDOCANNABINOIDS; KINETICS; MICE; PATCH-CLAMP TECHNIQUES; PURINERGIC AGONISTS; PURKINJE CELLS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2X; SODIUM CHANNEL BLOCKERS; SYNAPTIC POTENTIALS; SYNAPTIC TRANSMISSION;

EID: 79251488493     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01106.x     Document Type: Article

References (72)

1. Abbracchio MP, Burnstock G, (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475.
2. Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, et al. (2006). International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanism and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
4. Alger BE, (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68: 247-286.
5. Brenowitz SD, Regehr WG, (2003). Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. J Neurosci 23: 6373-6384.
6. Brenowitz SD, Best AR, Regehr WG, (2006). Sustained elevation of dendritic calcium evokes widespread endocannabinoid release and suppression of synapses onto cerebellar Purkinje cells. J Neurosci 26: 6841-6850.
7. Brockhaus J, Dressel D, Herold S, Deitmer JW, (2004). Purinergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices. Eur J Neurosci 19: 2221-2230.
8. Brown SP, Brenowitz SD, Regehr WG, (2003). Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat Neurosci 6: 1048-1057.
9. 2X receptor experessed in epithelia and brain. EMBO J 15: 55-62.
10. Burnstock G, (2006). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58: 58-86.
11. Burnstock G, (2007). Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483.
12. Chevaleyre V, Takahashi KA, Castillo PE, (2006). Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-75.
13. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16: 2495-2507.
14. Deitmer JW, Brockhaus J, Casel D, (2006). Modulation of synaptic activity in Purkinje neurons by ATP. Cerebellum 5: 49-54.
15. Di Angelantonio S, Nistri A, (2001). Calibration of agonist concentrations applied by pressure pulses or via rapid solution exchanger. J Neurosci Methods 110: 155-161.
16. Diana MA, Marty A, (2003). Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. J Neurosci 23: 5906-5918.
17. Diana MA, Levenes C, Mackie K, Marty A, (2002). Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J Neurosci 22: 200-208.
18. 2+ influx. Cell Calcium 44: 521-532.
19. Egan TM, Khakh BS, (2004). Contribution of calcium ions to P2X channel responses. J Neurosci 24: 3413-3420.
20. Fortin DA, Trettel J, Levine ES, (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92: 2105-2112.
21. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden KT, Jacobson KA, et al. (1997). Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18: 79-82.
22. Freiman I, Anton A, Monyer H, Urbanski MJ, Szabo B, (2006). Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice. J Physiol 575: 789-806.
23. Freund TF, Katona I, Piomelli D, (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066.
24. Galante M, Diana MA, (2004). Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci 24: 4865-4874.
25. Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford APDW, (2006). Pharmacology of P2X channels. Pflugers Arch 452: 513-537.
26. Glitsch M, Marty A, (1999). Presynaptic effects of NMDA in cerebellar Purkinje cells and interneurons. J Neurosci 19: 511-519.
27. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. (2002). International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
28. Illes P, Nieber K, Nörenberg W, (1996). Electrophysiological effects of ATP on brain neurons. Auton Pharmacol 16: 407-411.
29. Jarvis MF, Khakh BF, (2009). ATP-gated P2X cation channels. Neuropharmacol 56: 208-215.
30. + current in rat periaqueductal gray neurons. Neuropharmacol 41: 175-185.
31. 4 receptor orthologues. Br J Pharmacol 129: 388-394.
32. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M, (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
33. Kim J, Alger BE, (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7: 697-698.
34. Kim SJ, Kim YS, Yuan JP, Petralia RS, Worley PF, Linden DJ, (2003). Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature 426: 285-291.
35. Klotz KN, (2000). Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362: 382-391.
36. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, et al. (2008). The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3: e1797.
37. Kreitzer AC, Regehr WG, (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727.
38. 2+- currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J Neurosci 24: 2955-2965.
39. Lambrecht G, (2000). Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362: 340-350.
40. Lasser-Ross N, Ross WN, (1992). Imaging voltage and synaptically activated sodium transients in cerebellar Purkinje cells. Proc R Soc Lond 247: 35-39.
41. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176.
42. Lovinger DM, (2008). Presynaptic modulation by endocannabinoids. In:, Südhof TC, Starke K, (eds). Pharmacology of Neurotransmitter Release. Handbook of Experimental Pharmacology, Vol. 184. Springer Press: Berlin, Heidelberg, pp. 435-477.
43. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M, (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31: 463-475.
44. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase C β4 signaling cascade in the cerebellum. J Neurosci 25: 6826-6835.
45. Marcaggi P, Attwell D, (2005). Endocannabinoid signaling depends on the spatial pattern of synapse activation. Nat Neurosci 8: 776-781.
46. 2+ signals mediated by P2X-type purinoceptors in cultured cerebellar Purkinje cells. J Neurosci 18: 1704-1712.
47. Nörenberg W, Illes P, (2000). Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol 362: 324-339.
48. North RA, (2002). Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
49. Ohno-Shosaku T, Hashimotodani Y, Ano M, Takeda S, Tsubokawa H, Kano M, (2007). Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. J Physiol 584: 407-418.
50. Pertwee RG, (2005). Pharmacological actions of cannabinoids. In:, Pertwee R, (ed.). Cannabinoids. Handbook of Experimental Pharmacology, Vol. 168. Springer Press: Berlin, Heidelberg, New York, pp. 1-51.
51. Ralevic V, Burnstock G, (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.
52. Rancz EA, Häusser M, (2006). Dendritic calcium spikes are tunable triggers of cannabinoid release and short-term synaptic plasticity in cerebellar Purkinje neurons. J Neurosci 26: 5428-5437.
53. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, et al. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244.
54. Rogers M, Dani JA, (1995). Comparison of quantitative calcium flux through NMDA, ATP, and Ach receptor channels. Biophys J 68: 501-506.
55. Rubio ME, Soto F, (2001). Distinct localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci 21: 641-653.
56. Saitow F, Murakoshi T, Suzuki H, Konishu S, (2005). Metabotropic P2Y purinoceptor-mediated presynaptic and postsynaptic enhancement of cerebellar GABAergic transmission. J Neurosci 23: 2108-2116.
57. Stephens GJ, (2009). G-protein-coupled-receptor-mediated presynaptic inhibition in the cerebellum. Trends Pharmacol Sci 630: 421-430.
58. Straiker A, Mackie K, (2007). Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J Physiol 578: 773-785.
59. Stuart G, Häusser M, (1994). Initiation and spread of sodium action potentials in cerebellar Purkinje cells. Neuron 13: 703-712.
60. Szabo B, Schlicker E, (2005). Effects of cannabinoids on neurotransmission. In:, Pertwee R, (ed.). Cannabinoids. Handbook of Experimental Pharmacology, Vol. 168. Springer Press: Berlin, Heidelberg, New York, pp. 327-365.
61. Szabo B, Than M, Thorn D, Wallmichrath I, (2004). Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat. J Pharmacol Exp Ther 310: 915-925.
62. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Bär W, et al. (2006). Depolarization-induced retrograde synaptic inhibition in the cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol (Lond) 577: 263-280.
63. B receptors on inhibitory afferent neurons of Purkinje cells in the cerebellar cortex of the rat. Eur J Neurosci 15: 1575-1584.
64. 4a receptors. Mol Brain Res 64: 246-254.
65. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM, (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
66. Varma N, Carlson GC, Ledent C, Alger BE, (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21: RC188.
67. Von Kügelgen I, (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
68. Wallmichrath I, Szabo B, (2002). Cannabinoid inhibit striatonigral GABAergic neurotransmission in the mouse. Neuroscience 113: 671-682.
69. Wilson RI, Nicoll RA, (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592.
70. Witting A, Walter L, Wacker J, Möller T, Stella N, (2004). P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101: 3214-3219.
71. Xiang Z, Burnstock G, (2005). Changes in expression of P2X purinoceptors in rat cerebellum during postnatal development. Brain Res Dev Brain Res 156: 147-157.
72. Zimmermann H, (1996). Biochemistry, localisation and functional roles of ecto-nucleotidase in the nervous system. Prog Neurobiol 49: 589-618.